Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275920 · ClinicalTrials.gov registry record · NA
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2,211
- Enrollment target
NCT05275920: Completed NA study, sponsored by NYU Langone Health.
NCT05275920 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 2,211 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05275920, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,211 participants
- Enrollment target
Study Summary
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF) is a pragmatic, cluster-randomized, three-arm intervention trial that will compare the effectiveness of two targeted clinical decision support (CDS) intervention tools (best practice alert (BPA) and automated in-basket massage) to inform providers when a patient with heart failure and reduce ejection fraction (HFrEF) is not on appropriate medical therapy, as compared to usual care.
Interventions
- OTHER Best Practice Alert (BPA)
- OTHER In-Basket Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,211 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
What the finished NCT05275920 record still lists
NCT05275920 is an interventional study that assigns participants to a tested intervention. Its 2,211 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% higher).
The record links to 0 conditions, and to 2 interventions - of which Best Practice Alert (BPA) is the first listed.
NCT05275920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05275920 about?
NCT05275920 is a clinical study titled "Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)". Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF) is a pragmatic, cluster-randomized, three-arm intervention trial that will compare the effectiveness of two targeted clinical decision support (CDS) intervention tools (best practice al...
What is the current status of trial NCT05275920?
This trial is currently completed. It is a NA study. The enrollment target is 2,211 participants. The study started on 2022-04-28. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05275920?
The interventions under investigation include: Best Practice Alert (BPA) (OTHER), In-Basket Message (OTHER).
Who is sponsoring clinical trial NCT05275920?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05275920's enrollment target sits among peer trials
2,211 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI